Extract
CytoCore Reports Third Quarter Progress.
Pivotal Study of SoftPAP Showed Significant Improvements Over the Spatula/Cytobrush
26% Improvement in False Negatives and 33% Improvements in False Positives Revenue up 87% Year-Over-Year CHICAGO -- CytoCore Inc. (OTCBB:CYOE), the developer of a suite of cost-effective cervical cell collection devices for the early detection of...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Skiwear Goes Bold and Bright This Season | Arterial Remodeling Technologies ('ART') reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo ... | mark carey's chesapeake | Leaders, Thursday's Late Boxes | arrêté du 10 septembre 1992 modifiant l arrêté du 3 juillet 1992 portant désignation des candidats admis à suivre ... | Sentenza nº 7976 de Consiglio di Stato, December 27, 2006 | Sentenza nº 4111 de Tribunali Amministrativi Regionali, Sicilia, T.A.R. - Sicilia - Catania, December 31, 2004 | Decreti Decisorio nº 1051 de Tribunali Amministrativi Regionali Marche T.A.R - Marche Ancona August 18 2004
